Wireless midfield systems and methods
Implantable devices and/or sensors can be wirelessly powered by controlling and propagating electromagnetic waves in a patient's tissue. Such implantable devices/sensors can be implanted at target locations in a patient, to stimulate areas such as the heart, brain, spinal cord, or muscle tissue, and/or to sense biological, physiological, chemical attributes of the blood, tissue, and other patient parameters. The propagating electromagnetic waves can be generated with sub-wavelength structures configured to manipulate evanescent fields outside of tissue to generate the propagating waves inside the tissue. Methods of use are also described.
1. A method for using a mid-field system to temporarily sense a physiologic signal from a patient or to temporarily provide an electrostimulation therapy to the patient, the method comprising:
providing a mid-field receiver device at a target location in a patient body, the receiver device including an antenna configured to receive a wireless mid-field power signal from an external mid-field transmitter, and the receiver device further including at least one of a physiologic sensor configured to sense a physiologic signal from the target location or an electrode configured to provide an electrostimulation therapy at the target location;
transmitting a mid-field power signal using the mid-field transmitter, including manipulating evanescent fields outside of the patient body and thereby generating electromagnetic waves propagating inside the patient body;
receiving at least a portion of the mid-field power signal from the mid-field transmitter using the mid-field receiver device; and
in response to receiving the portion of the mid-field power signal, at least one of:
providing a temporary electrostimulation therapy to the target location using the electrode and a portion of the received mid-field power signal, and
sensing a physiologic signal from the target location using the physiologic sensor wherein the physiologic sensor is powered by the received mid-field power signal.
2. The method of claim 1 , wherein the sensing the physiologic signal from the target location includes sensing an evoked physiologic response.
3. The method of claim 1 , wherein the providing the mid-field receiver device at the target location includes delivering the mid-field receiver device using a catheter to position the mid-field receiver device within a targeted nerve or muscle region.
4. The method of claim 1 , wherein the providing the mid-field receiver device at the target location includes injecting the mid-field receiver device in a targeted nerve or muscle region.
5. The method of claim 1 , wherein the providing the mid-field receiver device at the target location includes providing a mid-field receiver device that does not include a physical lead configured to couple the receiver device to an external impulse generator.
6. The method of claim 1 , further comprising sensing the physiologic signal from the target location using the physiologic sensor; and
based on the sensed patient parameter, determining an efficacy of a temporary therapy provided to the patient.
7. The method of claim 1 , wherein the providing the mid-field receiver device at the target location in the patient body includes providing a mid-field receiver device at a neural target, wherein the mid-field receiver device is configured to deliver a temporary therapy to the neural tissue target.
8. The method of claim 1 , wherein the providing the mid-field receiver device at the target location in the patient body includes providing a mid-field receiver device at or in a muscle tissue target, wherein the mid-field receiver device is configured to deliver a temporary therapy to the muscle tissue target.
9. The method of claim 1 , wherein the providing the mid-field receiver device at the target location in the patient body includes providing a mid-field receiver device in or near a brain tissue target, wherein the mid-field receiver device is configured to deliver a temporary therapy to a brain tissue target.
10. The method of claim 1 , wherein the transmitting the mid-field power signal includes providing an excitation signal to at least one sub-wavelength structure in the external mid-field transmitter to thereby generate the mid-field power signal using the at least one sub-wavelength structure.
11. The method of claim 1 , wherein the transmitting the mid-field power signal includes transmitting a signal in a frequency range from about 300 MHz to about 3 GHz.
12. A method for providing a temporary treatment to an internal body tissue target using a mid-field receiver device, the method comprising:
receiving a wireless mid-field power signal at a mid-field receiver device that is implanted in a patient body, the power signal received from an external mid-field transmitter, wherein the wireless mid-field power signal comprises a portion of a propagating signal inside the patient body;
in response to receiving the wireless mid-field power signal at the mid-field receiver device, generating an electrostimulation therapy signal using a signal generator in the mid-field receiver device; and
providing the generated electrostimulation therapy signal to the tissue target using an electrode coupled to the mid-field receiver device.
13. The method of claim 12 , wherein the receiving the wireless mid-field power signal includes receiving a portion of a signal originated outside of the patient body and having a frequency at origination between about 300 MHz and about 3 GHz.
14. The method of claim 12 , further comprising providing an excitation signal to at least one sub-wavelength structure in an external mid-field transmitter and thereby generating the wireless mid-field power signal using the at least one sub-wavelength structure to manipulate evanescent fields outside of the patient body and generate the propagating signal inside the patient body.
15. The method of claim 12 , further comprising:
in response to receiving the wireless mid-field power signal at the mid-field receiver device, sensing a patient parameter using a physiologic sensor that is coupled to the implanted mid-field receiver device and that is powered by the received wireless mid-field power signal.
16. The method of claim 15 , further comprising determining an efficacy of a temporary treatment, provided to the tissue target by the mid-field receiver device, based on the sensed patient parameter.
17. A system configured to provide a temporary electrostimulation therapy to a patient using an implanted device, the system comprising:
an external mid-field transmitter configured to generate a mid-field power signal using at least one sub-wavelength structure to manipulate evanescent fields outside of the patient body and generate electromagnetic waves propagating inside the patient body; and
a mid-field receiver device, implanted at a target location inside the patient body, wherein the mid-field receiver device includes an antenna configured to receive the mid-field power signal from the external mid-field transmitter, and wherein the mid-field receiver device further includes at least one of a physiologic sensor configured to sense a physiologic parameter from the patient body or an electrode configured to provide a temporary electrostimulation therapy to a target inside the patient body.
18. The system of claim 17 , further comprising a catheter configured to carry the mid-field receiver device from outside the patient body to an implant location inside the patient body at a tissue target.
19. The system of claim 17 , wherein the external mid-field transmitter is configured to generate the mid-field power signal as an electromagnetic signal having a frequency between about 300 MHz and about 3 GHz.
20. The system of claim 17 , wherein the mid-field receiver device is a leadless device configured to receive operating power exclusively from the external mid-field transmitter.